This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Alexion Pharmaceuticals Inc (ALXN)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 944.00M 529.86M 989.50M 540.86M
Receivables 432.89M 421.75M 295.60M 244.29M
Inventories 176.44M 102.60M 94.52M 81.39M
Other Current Assets 0.00 18.93M 14.62M 4.75M
Total Current Assets 2.80B 2.19B 1.50B 941.27M
Property, Plant & Equipment, Gross 529.90M 305.21M 245.62M 226.46M
Accumulated Depreciation & Depletion 137.66M 104.10M 79.99M 60.61M
Property, Plant & Equipment, Net 392.25M 201.11M 165.63M 165.85M
Intangibles 587.05M 609.72M 646.68M 91.60M
Other Non-Current Assets 137.63M 62.54M 38.05M 12.52M
Total Non-Current Assets 1.41B 1.13B 1.12B 453.48M
Liabilities & Shareholder Equity
Total Assets 4.20B 3.32B 2.61B 1.39B
Accounts Payable 80.84M 145.89M 109.27M 37.78M
Short Term Debt 48.00M 48.00M 48.00M 727.00K
Other Current Liabilities 155.48M 228.84M 121.60M 50.78M
Total Current Liabilities 606.74M 582.43M 360.09M 230.22M
Long Term Debt 9.50M 65.00M 101.00M 0.00
Deferred Income Taxes 7.05M 101.24M 19.83M 0.00
Other Non-Current Liabilities 169.56M 154.72M 161.79M 29.85M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 293.20M 353.19M 282.62M 30.03M
Total Liabilities 899.94M 935.62M 642.71M 260.26M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 3.30B 2.38B 1.97B 1.13B
Common Par 20.00K 20.00K 20.00K 19.00K
Additional Paid In Capital 2.59B 2.11B 1.85B 1.26B
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 1.04B 379.10M 126.20M -128.62M
Treasury Stock -382.96M -80.36M -14.23M -2.68M
Other Equity Adjustments 56.78M -22.86M 6.64M 4.18M
Total Capitalization 3.31B 2.45B 2.07B 1.13B
Total Equity 3.30B 2.38B 1.97B 1.13B
Total Liabilities & Stock Equity 4.20B 3.32B 2.61B 1.39B
Total Common Shares Outstanding 199.06M 196.96M 194.69M 185.52M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 2.89M 985.00K 227.00K 97.00K
Basic Weighted Shares Outstanding 198.10M 195.53M 190.46M 183.22M
Diluted Weighted Shares Outstanding 201.62M 199.71M 198.50M 191.81M
Number of Employees 2273 1774 1373 1008
Number of Part-Time Employees 0 0 0 0

ALXN Alexion Pharmaceuticals Inc

Chart of ALXN

Analysts Ratings for ALXN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 13 15 14 14
Moderate Buy 0 0 0 0
Hold 4 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

ALXN Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Daily Swing Trade

Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.

Product Features:
  • Daily commentary and coaching on swing trading
  • Technical charts and analysis
Top Rated Stocks Top Rated Funds Top Rated ETFs